Atlas Trials

Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%

Clinical trial NCT00090194 · TERMINATED

Trial details

NCT number
NCT00090194
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Kidney Failure, Chronic
Start date
2003-06-01
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.